The healthcare industry has been buzzing with excitement after the CGHS rate revision. Nuvama Institutional Equities called it a “welcome development for the sector,” a fiscal catalyst that lands right when private hospitals are in the middle of a massive bed expansion cycle and facing disputes with insurers over reimbursements.

Nuvama on Healthcare sector: A fiscal boost arriving just in time

Nuvama noted that median price hikes across procedures are around 100%, while some, especially heart transplants and complex neurosurgeries, have seen revisions as high as 3–6 times the earlier rate.

For instance, the CGHS rate for a heart transplant has increased from Rs 3.17 lakh to Rs 15 lakh, and a cervical laminectomy from Rs 26,450 to Rs 53,000. These jumps, Nuvama says, will materially impr

See Full Page